Tweet
Molina Healthcare, Inc. (NYSE:MOH) Director Daniel Cooperman sold 943 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $133.81, for a total value of $126,182.83. The sale was disclosed in a filing with the SEC, which is available at this link .
NYSE:MOH opened at $134.15 on Friday. The company has a market cap of $7.97 billion, a P/E ratio of 239.55, a PEG ratio of 1.26 and a beta of 1.22. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.73. Molina Healthcare, Inc. has a 1-year low of $58.48 and a 1-year high of $135.42. Get Molina Healthcare alerts:
Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Tuesday, July 31st. The company reported $3.08 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.09 by $1.99. The business had revenue of $4.88 billion during the quarter, compared to analysts' expectations of $4.67 billion. Molina Healthcare had a positive return on equity of 23.01% and a negative net margin of 0.26%. The firm's revenue for the quarter was down 2.3% compared to the same quarter last year. During the same period last year, the firm posted ($4.01) EPS. equities research analysts forecast that Molina Healthcare, Inc. will post 6.67 earnings per share for the current year. Several research analysts have recently commented on MOH shares. Zacks Investment Research upgraded Molina Healthcare from a "hold" rating to a "buy" rating and set a $120.00 target price for the company in a research note on Tuesday, July 24th. BMO Capital Markets lifted their target price on Molina Healthcare from $85.00 to $94.00 and gave the stock a "market perform" rating in a research note on Friday, June 1st. Barclays began coverage on Molina Healthcare in a report on Monday, July 23rd. They set an "equal weight" rating and a $105.00 price target for the company. Morgan Stanley lifted their price target on Molina Healthcare from $91.00 to $100.00 and gave the stock an "overweight" rating in a report on Tuesday, May 1st. Finally, SunTrust Banks lifted their price target on Molina Healthcare to $120.00 and gave the stock a "buy" rating in a report on Tuesday, July 10th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company. The stock currently has a consensus rating of "Hold" and an average target price of $110.62.
A number of large investors have recently added to or reduced their stakes in MOH. Advisors Asset Management Inc. lifted its holdings in Molina Healthcare by 2,264.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company's stock worth $118,000 after purchasing an additional 89,845 shares during the last quarter. Integrated Investment Consultants LLC acquired a new position in Molina Healthcare in the 2nd quarter valued at $165,000. Contravisory Investment Management Inc. acquired a new position in Molina Healthcare in the 2nd quarter valued at $166,000. Eaton Vance Management acquired a new position in Molina Healthcare in the 1st quarter valued at $203,000. Finally, Zeke Capital Advisors LLC acquired a new position in Molina Healthcare in the 2nd quarter valued at $206,000.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other